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Quality review and education as method of improving guideline adherence for medication prescription and 
outcomes among vascular interventionalists performing non-cardiac vascular surgeries
Alejandro Perez, MD; Shih-Ting Chiu, PhD; Amy Manning, RN; Brant Ullery, MD
Background
• Medical management of patients undergoing non-cardiac vascular procedures often sub-
optimally follow evidence based guidelines.
• Rates of statin and antiplatelet use in abdominal aortic aneurysm setting have been measured 
to be 63-75% (1).
• Rates of statin prescription have been estimated to be 75% and antiplatelet therapy 93% in 
setting of carotid artery disease related surgery (2). 
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Results
• 826 patients were evaluated. 400 patients were in pre new database implementation and 426 
were included after implementation. 21 open abdominal aortic surgeries were excluded from 
the comparisons because they did not have all historical and post-op comorbidities coded the 
same as the other procedures in the database.
• Clinical outcomes evaluated:  In-Hospital/Thirty-days/One-year Mortality, Length of Stay, Access 
Site Complication, Stroke, TIA, MI, Bleed, HTN, Infection, Re-operation, Any antiplatelet at 
discharge, Statin at Discharge, ASA at Discharge, Beta Blockers at Discharge, and ACE-Inhibitor 
at Discharge
• Table demonstrates baseline demographic information.





We hypothesized that feedback to practitioners in regards to outcomes and medications 
prescribed would improve care and lead to improved clinical outcomes.
Methods
• With conversion to new database in 2015 that allowed for more comprehensive tracking of 
vascular surgery outcomes, a decision was made to share these data with vascular 
interventionalists on regular basis as well as relay medications prescribed at discharge of index 
non-cardiac vascular surgery. 
• Carotid and abdominal aortic surgeries were evaluated. 
• The most frequent format for presentation of data to vascular interventionalists was vascular 
morbidity and mortality conference which is scheduled as monthly forum. 
• Medications included in presentations were antiplatelet and statin therapies. Comparisons were 
made between adherence to guideline based therapies 2 years before and 2 years after new 
database implementation. 
• ACE inhibitor/aldosterone receptor blocker (ARB) therapy prescribing data were not included in 
these presentations. 
• SAS Enterprise Guide 7.1 and R 3.6.1 software used for analysis.
Conclusions
• Regular feedback to vascular practitioners improves adherence to guideline based therapies 
and can improve surgical outcomes.
Results
• No significant difference found with prescribing of ACE inhibitors/ARB, changing only from 47 to 
48%. 
• Use of antiplatelet and statin therapies have higher adherence both before and after 
intervention in carotid surgery vs. abdominal aortic surgery. See Figure 1.
• There was difference with univariate analysis of antiplatelet and statin prescribing for all 
surgeries. Antiplatelet prescribing improved from 89 to 93%, Odds Ratio (OR) = 1.7 (95% 
confidence interval, 1-2.8) and statin prescribing improved from 74 to 86%, OR= 2.1 (1.5-3). See 
Figure 2.
• Access site and bleeding complications also demonstrated improvement.
• Remainder of clinical outcomes without demonstrate difference after intervention of education 
and new database implementation
• Multivariate analysis demonstrated continued reduced incidence of access site complications, 
OR = 0.2 (0.1-0.4).
• Bleeding, antiplatelet prescription at discharge and statin prescription at discharge with 
intervention of education with new database implementation no longer statistically significant 
with multivariate analysis.













Procedures CAS 20 5 70 17 90 11
CEA 222 58 229 54 451 56
EVAR 142 37 122 29 264 33
Urgency Elective 348 91 347 82 695 86
Urgent/Emergent 36 9 74 18 110 14
Age Mean (SD) 73 9 72 9 72 9
Gender Female 113 30 139 33 252 31
Male 270 71 282 67 552 69
Race Caucasian 377 98 399 95 776 96
Non-Caucasian or Unknown 7 2 22 5 29 4
BMI Mean (SD) 28 8 29 6 29 7
Smoking Never 85 22 86 20 171 21
Prior 193 51 222 53 415 52
Current 101 27 113 27 214 27
Hypertension No 61 16 62 15 123 15
Yes (>=140/90 or history) 323 84 358 85 681 85
Diabetes No 289 75 282 67 571 71
Yes 95 25 138 33 233 29
CAD No 231 60 315 75 546 68
Yes 153 40 106 25 259 32
Prior CABG No 314 82 349 83 663 83
Yes 68 18 72 17 140 17
Prior CHF No 361 94 396 94 757 94
Yes 23 6 25 6 48 6
COPD No 316 82 300 71 616 77
Yes 68 18 121 29 189 23
Dialysis No 382 99 418 99 800 99
Yes 2 1 3 1 5 1
Living status Home 380 99 415 99 795 99
Nursing home/SNF/Assisted 2 1 6 1 8 1
Other 1 0 0 0 1 0
ASA Class 1 1 0 0 0 1 0
2 17 4 23 8 40 6
3 273 72 198 67 471 70
4 85 22 75 25 160 24
Emergency 4 1 0 0 4 1
Prior PVI/Bypass No 325 85 319 76 644 80
Yes 57 15 101 24 158 20
Prior CEA/CAS No 335 88 374 89 709 88
Yes 47 12 47 11 94 12
Pre-op Beta Blockers No 180 47 197 47 377 47
Yes 194 51 199 47 393 49
Op Day only 9 2 25 6 34 4
Pre-op ACE-
Inhibitor/ARB
No 165 43 179 43 344 43
Yes 219 57 242 57 461 57
Prior TIA/Stroke No 225 59 217 52 442 55
Yes 159 41 204 48 363 45
• Potentially larger sample size and duration of follow up would have shown larger effect 
on outcomes. 
• Antiplatelet therapy already had high usage rate for patients studied undergoing non-
cardiac vascular surgeries, but statin therapy usage lagged behind as has been shown 
in prior literature. Statin therapies need more strategies to ensure more widespread 
use.
• This study demonstrates how frequent education can improve adherence to evidence 
based treatment strategies with perhaps most impact on statin use in abdominal aortic 
surgeries.
Discussion
Figure 2. Odds Ratio (95% Confidence interval) of Prescribing antiplatelet and statin therapies, 
access site complications and bleeding in patients undergoing open carotid and abdominal 
aortic procedures with implementation of new quality reporting database and education 
strategy
Table. Patient Demographics (Significant differences detected between cohorts were colored)
Figure 1. Medications at discharge by procedures. We used logistic regression to detect the 
significant variance with both Pre/Post cohorts, and different procedure in a model. P-values 
for grouping and procedure effects were 0.1494, and <.0001, respectively for Antiplatelet; and 
were 0.0002, and 0.0002, respectively for Statin.
